119 related articles for article (PubMed ID: 1491178)
1. Serum prolactin levels in women with gross cystic breast disease.
Vizoso F; Allende MT; García-Muñiz JL; Alexandre E; Fueyo A; Ruibal A
Int J Biol Markers; 1992; 7(4):225-9. PubMed ID: 1491178
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of human breast cysts according to their biochemical and hormonal composition, and cytologic examination.
Vizoso F; Fueyo A; Allende MT; Fernández J; García-Morán M; Ruibal A
Eur J Surg Oncol; 1990 Jun; 16(3):209-14. PubMed ID: 2140797
[TBL] [Abstract][Full Text] [Related]
3. Prolactin and thyrotropin response to thyrotropin-releasing hormone in premenopausal women with fibrocystic disease of the breast.
Dogliotti L; Faggiuolo R; Ferusso A; Orlandi F; Sandrucci S; Tibo A; Angeli A
Horm Res; 1985; 21(3):137-44. PubMed ID: 3922866
[TBL] [Abstract][Full Text] [Related]
4. Prolactin secretion in benign breast diseases.
Sitruk-Ware R; Clair F; Sterkers N; Ulmann A; Mauvais-Jarvis P
Gynecol Endocrinol; 1987 Jun; 1(2):195-200. PubMed ID: 3140581
[TBL] [Abstract][Full Text] [Related]
5. Serum prolactin levels in patients with fibrocystic breast disease.
Peters F; Schuth W; Scheurich B; Breckwoldt M
Obstet Gynecol; 1984 Sep; 64(3):381-5. PubMed ID: 6431348
[TBL] [Abstract][Full Text] [Related]
6. Relationship between serum prolactin levels and protein composition of breast secretions in nonlactating women.
Vizoso F; Díez-Itza I; Sánchez LM; Tuya AF; Ruibal A; López-Otín C
J Clin Endocrinol Metab; 1994 Aug; 79(2):525-9. PubMed ID: 8045972
[TBL] [Abstract][Full Text] [Related]
7. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
[TBL] [Abstract][Full Text] [Related]
8. [Mastopathy and breast cancer: is there a typical hormone profile?].
Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
[TBL] [Abstract][Full Text] [Related]
9. Changes in the prolactin response to thyrotropin-releasing hormone (TRH) during the menstrual cycle of normal women.
Boyd AE; Sanchez-Franco F
J Clin Endocrinol Metab; 1977 May; 44(5):985-9. PubMed ID: 404311
[TBL] [Abstract][Full Text] [Related]
10. [GnRH-TRH stimulation tests in patients with mastopathy].
Kasch R; Meissner J; Kunkel S
Zentralbl Gynakol; 1988; 110(5):298-303. PubMed ID: 3131977
[TBL] [Abstract][Full Text] [Related]
11. Release of prolactin, thyrotropin, and growth hormone in women with cyclical mastalgia and fibrocystic disease of the breast.
Watt-Boolsen S; Eskildsen PC; Blaehr H
Cancer; 1985 Aug; 56(3):500-2. PubMed ID: 4005811
[TBL] [Abstract][Full Text] [Related]
12. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
Andreassen B; Huth J; Tyson JE
Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a correlation between CA15.3 and prolactin serum levels after TRH administration in women with gross cystic breast disease.
Vizoso F; Allende MT; Fueyo A; Riera L; López Otin C; Ruibal A
Int J Biol Markers; 1991; 6(1):31-2. PubMed ID: 1906915
[No Abstract] [Full Text] [Related]
14. Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content.
Boccardo F; Valenti G; Zanardi S; Cerruti G; Fassio T; Bruzzi P; De Franchis V; Barreca A; Del Monte P; Minuto F
Cancer Res; 1988 Oct; 48(20):5860-3. PubMed ID: 2971432
[TBL] [Abstract][Full Text] [Related]
15. Lipid-associated sialic acid levels in human breast cyst fluids.
Mannello F; Bocchiotti G; Troccoli R; Gazzanelli G
Breast Cancer Res Treat; 1992; 24(2):167-70. PubMed ID: 8443404
[TBL] [Abstract][Full Text] [Related]
16. Ultradian (12-hr) significant component in serum prolactin of healthy women and patients with fibrocystic mastopathy.
D'Allesandro B; Esposito V; Lo Iudice G; Cagnoni M; Tarquini B
Prog Clin Biol Res; 1987; 227B():281-4. PubMed ID: 3628338
[TBL] [Abstract][Full Text] [Related]
17. [Hormonal abnormalities in women with breast cysts].
Wypych K; Kuźlik R; Wypych P
Ginekol Pol; 2002 Nov; 73(11):1117-25. PubMed ID: 12722409
[TBL] [Abstract][Full Text] [Related]
18. Prolactin response to thyrotropin-releasing hormone in early and advanced human breast cancer.
Barni S; Lissoni P; Tancini G; Crispino S; Paolorossi F; Rovelli F; Fumagalli G; Ferri L
Tumori; 1986 Aug; 72(4):399-403. PubMed ID: 3094215
[TBL] [Abstract][Full Text] [Related]
19. Prolactin response to thyrotropin-releasing hormone in women with infertility and/or randomly elevated serum prolactin levels.
Archer DF
Fertil Steril; 1987 Apr; 47(4):559-64. PubMed ID: 3106094
[TBL] [Abstract][Full Text] [Related]
20. The effect of thyrotropin-releasing hormone stimulation on serum levels of gonadotropins in women during the follicular and luteal phases of the menstrual cycle.
Colon JM; Lessing JB; Yavetz C; Peyser MR; Ganguly M; Weiss G
Fertil Steril; 1988 May; 49(5):809-12. PubMed ID: 3129315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
